Sale of Cerba Healthcare to Partners Group and PSP Investments

Partners Group and PSP Investments have finalized the acquisition of Cerba HealthCare, a leading European operator of clinical pathology laboratories, from PAI Partners. Partners Group, the global private markets investment manager, acting on behalf of its clients, and the Public Sector Pension Investment Board ("PSP Investments"), one of Canada's largest pension investment managers, have finalized the acquisition of European medical laboratory services operator, Cerba HealthCare ("Cerba", "the Company"). Cerba is being acquired from PAI Partners, a leading European private equity firm, and from Cerba clinical pathologists and managers, for approximately 1.8 billion euros. Partners Group and PSP Investments are enthusiastic about collaborating with Cerba HealthCare’s team, under the direction of Catherine Courboillet to support the Group’s growth, in particular its international development, to accompany the consolidation of the French, Belgian and Luxembourg markets and strengthen its strategy of innovation and diversification.